Adenosine Pathway
Showing 1 - 25 of 3,177
Pancreatic Ductal Adenocarcinoma Trial in New York (Stereotactic body radiotherapy (SBRT), Zimberelimab, Quemliclustat)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Stereotactic body radiotherapy (SBRT)
- +4 more
-
New York, New YorkColumbia University Irving Medical Center
Sep 15, 2023
Solid Tumor, Adult Trial in Korea, Republic of, United States (TTX-030, budigalimab and mFOLFOX6, TTX-030, budigalimab and
Active, not recruiting
- Solid Tumor, Adult
- TTX-030, budigalimab and mFOLFOX6
- +7 more
-
Scottsdale, Arizona
- +31 more
Oct 18, 2022
Diarrhea-predominant Irritable Boewl Syndrome Trial in Beijing (Modified Gegen Qinlian Decoction)
Recruiting
- Diarrhea-predominant Irritable Boewl Syndrome
- Modified Gegen Qinlian Decoction
-
Beijing, Beijing, ChinaXiyuanhospital
Mar 13, 2020
Myocardial Infarction, Myocardial Fibrosis, Myocardial Remodeling, Ventricular Trial in Messina (P2Y12 Potent Inhibitor +
Recruiting
- Myocardial Infarction
- +2 more
- P2Y12 Potent Inhibitor + Aspirin for STEMI patients
- Clopidogrel + Aspirin for CCS patients
-
Messina, ItalyAOU Policlinico G. Martino
Jan 21, 2023
Oligometastatic Prostate Cancer Trial in New York (Quemliclustat, Etrumadenant, Zimberelimab)
Not yet recruiting
- Oligometastatic Prostate Cancer
- Quemliclustat
- +3 more
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Jun 14, 2023
Pancreatic Cancer Trial (TTX-030, nab-paclitaxel and gemcitabine, TTX-030, budigalimab, nab-paclitaxel and gemcitabine,
Not yet recruiting
- Pancreatic Cancer
- TTX-030, nab-paclitaxel and gemcitabine
- +2 more
- (no location specified)
Nov 3, 2023
Ulcerative Colitis Trial in Beijing (Modified Gegen Qinlian Decoction)
Recruiting
- Ulcerative Colitis
- Modified Gegen Qinlian Decoction
-
Beijing, Beijing, ChinaXiyuanhospital
Oct 11, 2019
Cancer in Inherited Bone Marrow Failure Syndromes
Recruiting
- Diamond Blackfan Anemia
- +4 more
-
Bethesda, Maryland
- +1 more
Jan 24, 2023
Breast Cancer Trial in Marseille (M1774, Fulvestrant injection)
Not yet recruiting
- Breast Cancer
- M1774
- Fulvestrant injection
-
Marseille, FranceInstitut Paoli Calmettes
Aug 9, 2023
Metastatic Castration-resistant Prostate Cancer, Prostate Cancer Trial in United States (SRF617, etrumadenant, zimberelimab)
Recruiting
- Metastatic Castration-resistant Prostate Cancer
- Prostate Cancer
- SRF617
- +2 more
-
Miami, Florida
- +6 more
Jun 13, 2022
Well Differentiated Pancreatic Endocrine Tumor Trial in Milano (Everolimus plus Octreotide LAR plus Metformin)
Active, not recruiting
- Well Differentiated Pancreatic Endocrine Tumor
- Everolimus plus Octreotide LAR plus Metformin
-
Milano, ItalyFondazione IRCCS Istituto Tumori Milano
Sep 3, 2021
Soft-tissue Sarcoma Trial in Philadelphia (TAK-228)
Terminated
- Soft-tissue Sarcoma
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Sep 19, 2022
Heart Failure With Preserved Ejection Fraction, Diabete Type 2 Trial in Cairo (Metformin)
Not yet recruiting
- Heart Failure With Preserved Ejection Fraction
- Diabete Type 2
-
Cairo, Egyptclinical research uint- El-sheikh zayed specialized hospital SMC
Oct 8, 2023
Cough Trial (device, diagnostic test, procedure)
Not yet recruiting
- Cough
- Adenosine triphosphate (ATP) solution inhalation from nebuliser
- +7 more
- (no location specified)
Jan 26, 2023
NSCLC Trial in Marseille (Durvalumab (MEDI4736), Monalizumab (IPH2201), Oleclumab (MEDI9447))
Recruiting
- Non-small Cell Lung Cancer
- Durvalumab (MEDI4736)
- +5 more
-
Marseille, FranceAssistance Publique Hopitaux de Marseille
Sep 21, 2022
Breast Cancer, Breast Tumors, Cancer of Breast Trial in New York (Metformin, Atorvastatin, Breast surgery)
Active, not recruiting
- Breast Cancer
- +2 more
- Metformin
- +2 more
-
New York, New YorkColumbia University Medical Center - Herbert Irving Cancer Cente
Aug 16, 2022
Inhaled Nitric Oxide Responsiveness in Patients With PPHN
Withdrawn
- PPHN
- Hypoxic Respiratory Failure
- (no location specified)
Sep 12, 2023
Cardiac Tissue in Postnatal Development
Recruiting
- Congenital Heart Disease
- Tetralogy of Fallot
-
Atlanta, GeorgiaEmory University School of Medicine
Jun 21, 2022
Syncope Trial in Milan (adenosine dosage)
Completed
- Syncope
- adenosine dosage
-
Milan, MI, ItalyIRCCS Istituto Auxologico Italiano
Mar 23, 2023
Efficacy and Adverse Effects of Olaparib in Ovarian Cancer.
Enrolling by invitation
- Ovarian Cancer
-
Xi'an, Shaanxi, ChinaThe First Affliated Hospital of Xi'an Jiaotong University
Mar 23, 2022
Advanced Solid Tumor, Metastatic Cancer, Refractory Cancer Trial in Huntersville, Houston, Webster (PT199, Anti-PD-1 mAb)
Recruiting
- Advanced Solid Tumor
- +18 more
- PT199
- Anti-PD-1 monoclonal antibody
-
Huntersville, North Carolina
- +2 more
Aug 10, 2022
Respiratory Failure Trial in Boston (Normoxia with Normocarbia, Normoxia with Hypercarbia, Hyperoxia with Normocarbia)
Terminated
- Respiratory Failure
- Normoxia with Normocarbia
- +3 more
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 7, 2022
Cough Trial in Parkville (Adenosine Triphosphate, Capsaicin, Functional Brain Imaging)
Completed
- Cough
- Adenosine Triphosphate
- +2 more
-
Parkville, Victoria, AustraliaThe University of Melbourne
Jun 10, 2022